[4-prenyl-1,2-diphenyl-3,5-pyrazolidindione (DA 2370) in rheumatoid arthritis: clinical study with the use of a new weighted articular index]
[Article in
Italian]
- PMID: 4549698
Item in Clipboard
[4-prenyl-1,2-diphenyl-3,5-pyrazolidindione (DA 2370) in rheumatoid arthritis: clinical study with the use of a new weighted articular index]
[Article in
Italian]
Reumatismo.
1972 Jul-Sep.
No abstract available
Similar articles
-
[Clinical evaluation of feprazone in rheumatoid arthritis (author's transl)].Ryumachi. 1979 Apr;19(2):147-63. Ryumachi. 1979. PMID: 375431 Clinical Trial. Japanese. No abstract available.
-
Safety and efficacy of feprazone for long-term treatment of rheumatoid arthritis and osteoarthritis.Clin Ther. 1981;3(5):349-55. Clin Ther. 1981. PMID: 7471130
-
The use of thermography in the evaluation of the anti-inflammatory activity of feprazone on rheumatoid arthritis.Arzneimittelforschung. 1982;32(4):427-9. Arzneimittelforschung. 1982. PMID: 7201815
-
[Effect of non-steroidal anti-inflammatory agents on kidney function in patients with rheumatoid arthritis].Revmatologiia (Mosk). 1991 Apr-Jun;(2):28-30. Revmatologiia (Mosk). 1991. PMID: 1925261 Review. Russian. No abstract available.
-
Disease-modifying drugs in rheumatoid arthritis.Practitioner. 2001 Dec;245(1629):1018-25. Practitioner. 2001. PMID: 11771221 Review. No abstract available.